# Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC

> **NCT04304638** · — · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 450 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer
- Stage III Non-small-cell Lung Cancer
- EGFR Mutation-Related Tumors

## Interventions

- **RADIATION:** radiation or chemo-radiation
- **DRUG:** EGFR-TKI Inhibitor

## Key facts

- **NCT ID:** NCT04304638
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03
- **Primary completion:** 2020-05
- **Final completion:** 2020-06
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04304638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04304638, "Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04304638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*